National Pharmaceutical Pricing Authority (NPPA) has condemned false statements regarding its connivance in any malpractices adopted by Pharmaceutical Companies.
NPPA is a regulatory body under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers .
NPPA is committed to ensure affordability and accessibility of medicines by fixing the ceiling price for scheduled formulations and monitoring the prices of non-scheduled formulations.
An English newspaper from Jammu has reported that the Jammu Pharmaceutical Distributors Association (JDPA) has alleged pharmaceutical companies for resorting corrupt practices by selling most of the medicines at different prices to different sectors despite having same MRP with active connivance of the NPPA.
NPPA has strongly condemned such false statements regarding its connivance in any of the malpractices adopted by the pharmaceutical companies.
It further said, charging different prices below the applicable ceiling price or MRP to different sectors by pharmaceutical companies is not under the purview of NPPA.